Financial results for the quarter ended Jun 2014 are in and we have tabulated them for you in this report.
You can download this report as a Capital Mind Premium Member.
We have tabulated summary results for all companies with a market cap of more than 1,000 cr., and divided them into sectors.
Till August 18, 2014, 480 such companies have announced results with a combined turnover of 14.50 trillion (lakh cr.). For the total, average profit growth has been -5.66% and EPS growth (average) was -11.46%. (The lower EPS growth is usually due to issue of shares, which many companies have had to, including banks)
50 companies more than doubled net profit, a good sign.
Capital Mind will update this report regularly and provide a note at Capital Mind Premium when updated. Please feel free to contact us for any corrections or changes. Starting Q1 FY 2015, this will be a regular feature at Capital Mind.
- All figures in Rs. Cr. except EPS, which is in rupees.
- NP = Net Profit After Tax
- Rev = Revenue
- EPS = Earnings Per Share (Adjusted for Bonuses and Splits)
- Only Companies with Market Cap of more than Rs. 1000 cr.
- Growth totals are added up for Revenue/Profits, but Averaged for the Annual Growth Percentages.
- Sector Classifications are ours – please feel free to correct us as necessary.
- Where earnings go from profit to loss or vice versa, things go a little crazy with the profit and EPS growth percentages. Please ignore them.
The financial results of 50 Nifty companies are out and we seem to have a good quarter on our hands, with average EPS growth of 15.8%. An outlier exists in the form of Sesa Sterlite, which, by virtue of its merger with Sterlite and having to include Cairn in consolidation, saw a huge increase in the outstanding number of shares, and also had a one-time hit of Rs. 1650 cr. due to an accounting change. Minus Sesa Sterlite and Cairn we will still see EPS growth of 14%.
Sun Pharma on the other hand saw a 208.1% jump in EPS. A closer look reveals that this was mainly due to an exceptional item last year to the tune of Rs -25,174.10 cr. Instead, comparing income without exceptional items, they showed a growth of 12.22%. Tata Motors had a 211.3% growth in EPS, owing to strong growth in revenues.
In the table, we have a list of all Nifty companies with results. We’ve used consolidated results where we can, and have adjusted past EPS for bonuses or splits. If we have something wrong, please let us know. (All figures are in Rs. Cr. except Earnings Per Share.)
Outstanding in their contributions are:
- Lupin and Dr. Reddys with excellent 50%+ EPS growth in the Pharma space.
- Tata Motors with a 211.3% growth in EPS;
- TCS, HCL Tech and Wipro did 25%+ (TCS stands out!).
- Tata Steel’s profits fell 73%. The profits of BHEL, too, fell more than 50%.
- DLF dropped EPS 30%., Gail was -23%.